Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06613971 · ClinicalTrials.gov registry record
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
A clinical trial of Dementia and Dementia Alzheimer Type, sponsored by MD Stem Cells.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06613971: Recruiting study of Dementia and Dementia Alzheimer Type, sponsored by MD Stem Cells.
NCT06613971 is a study of Dementia and Dementia Alzheimer Type that is actively recruiting participants, run by MD Stem Cells. The registered enrollment target is 50 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06613971, a study of Dementia and Dementia Alzheimer Type, is actively recruiting participants, sponsored by MD Stem Cells.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a human clinical study making a noninvasive measurement from a patient's eye to determine whether there is a quantitative difference in measurements between patients with and without the diagnosis of dementia.
Primary Outcome
Dynamic light scattering will be compared between patients with dementias and patients with no cerebral pathology.
Conditions Studied
Study Locations (1)
Florida
- 3T Radiology - Coconut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2028-04-25 |
What NCT06613971 shows while recruiting
NCT06613971 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT06613971 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06613971 about?
NCT06613971 is a clinical study titled "Dynamic Light Scattering Ocular Measurement in the Detection of Dementia". This is a human clinical study making a noninvasive measurement from a patient's eye to determine whether there is a quantitative difference in measurements between patients with and without the diagnosis of dementia.
What is the current status of trial NCT06613971?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-04-25. Estimated completion is 2028-04-25.
What conditions does trial NCT06613971 study?
This clinical trial studies the following conditions: Dementia, Dementia Alzheimer Type.
Who is sponsoring clinical trial NCT06613971?
This trial is sponsored by MD Stem Cells, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06613971 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06613971's enrollment target sits among peer trials
50 153rd of 199 higher than 44 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
-
Genetic Characterization of Movement Disorders and Dementias
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI